Navigation Links
Advanced targeted therapies effective as first-line treatment for lung cancer
Date:8/1/2009

CLINICAL OUTCOME WITH ERLOTINIB: RESULTS FROM THE PHASE III PLACEBO-CONTROLLED SATURN STUDY OF MAINTENANCE THERAPY FOR ADVANCED NSCLC (ABSTRACT # B9.1)

In another segment of the SATURN study, researchers further examined the efficacy of erlotinib as a maintenance therapy in non-progressive disease patients after first-line platinum-containing chemotherapy. Currently the indications for erlotinib are limited to its use as a second- or third-line agent after failure of first-line chemotherapy.

To expand the potential for the use of erlotinib, Wolfram Brugger, M.D., Ph.D., head of the Department of Hematology, Oncology and Immunology at Schwarzwald-Baar Clinic in Germany, and his team of researchers conducted the phase III, placebo-controlled SATURN study to evaluate the efficacy of erlotinib as a maintenance therapy.

Dr. Brugger enrolled a total of 889 non-small cell lung cancer (NSCLC) patients and treated them with either 150mg/day of erlotinib or placebo after four cycles of platinum-based doublet chemotherapy. Researchers evaluated molecular markers including EGFR protein and EGFR gene copy number, EGFR- and KRAS-mutations and EGFR polymorphism in order to potentially identify predictive markers for erlotinib therapy.

Both arms of the trial were well represented in patient and disease characteristics, specifically regarding biomarker status. Dr. Brugger and his team determined that the use of erlotinib provided a clinical benefit in terms of both progression-free and overall survival for all patients, regardless of the status of biomarkers.

"This study demonstrates the tremendous potential for erlotinib and the potential for its expanded use as a maintenance therapy," says Dr. Brugger. "The addition of an effective tool physicians can use to maintain a cancer-free state in their patients is crucial to prolonged survival."

Dr. Brugger will present this study on Saturday, August 1 at 2:30 pm PT in Moscon
'/>"/>

Contact: Liz Wulderk
lwulderk@spectrumscience.com
443-506-1931
International Association for the Study of Lung Cancer
Source:Eurekalert

Page: 1 2 3 4 5 6 7 8

Related medicine news :

1. Smith & Nephew Highlights Advanced Wound Management Progress
2. Patient safety advanced by revised heparin standards
3. AstraZeneca Submits New Drug Applications for ZACTIMA(TM) in Second-Line Advanced Non-Small Cell Lung Cancer
4. Penile Prosthesis Surgery Infection Rates Reduced With The No-Touch Technique By Dr. J. Francois Eid of Advanced Urological Care
5. Leading Independent Analyst Firm States Silver Creek Systems Holds A Virtual Monopoly In Delivering Advanced Product Data Quality Capabilities
6. Surgery remans an option for advanced lung cancer
7. Nexavar in Combination with Chemotherapy Shown to Extend Progression-Free Survival in Patients with Advanced Breast Cancer
8. Hendrick Health System Deploys Sentillions Tap & Go Advanced Authentication Solution
9. Centocor Ortho Biotech Statement on the FDA ODAC Opinion Regarding DOXIL(R) for Treatment of Advanced Breast Cancer
10. Marienkrankenhaus Hamburg Installs Visage(R) CS Enterprise Wide Advanced Visualization Solutions
11. Advanced Bag Design for Cryopreservation: The New CryoMACS(R) Freezing Bag
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/3/2015)... 03, 2015 Alberto Grignolo, PhD, will ... upcoming Annual Meeting. DIA’s Global Inspire Award program recognizes ... excellence, and commitment to service on a global scale. ... Award that annually recognizes one DIA member for meritorious ... mission of DIA to foster innovation to improve health ...
(Date:6/3/2015)... Washington, DC (PRWEB) June 03, 2015 ... Global Inspire Award at DIA’s upcoming Annual Meeting. DIA’s ... for their leadership, level of excellence, and commitment to ... will receive the President’s Award for Outstanding Contribution to ... and innovative contributions to advancing global health. ...
(Date:6/3/2015)... Researchers at the University of Western ... say the tried-and-true marker mesothelin is the best option ... the research. Click here to read it now. ... Asbestos Related Diseases say, even though a mesothelin test ... preferable to fibulin-3 for identifying mesothelioma. , “Preliminary ...
(Date:6/3/2015)... June 03, 2015 On Sunday, June ... world will gather in their local communities to observe ... cities across the U.S. and abroad will hold celebrations ... attention to the ongoing challenges of cancer survivorship, and ... diagnosis can be fruitful, rewarding, and inspiring.,  , National ...
(Date:6/3/2015)... are challenging and unpredictable times for traditional organizations across ... are rewriting the rules for business as we knew ... businesses to take on a more agile approach in ... On top of this there is a growing trend ... new innovation and approaches to business. , The manager ...
Breaking Medicine News(10 mins):Health News:Longtime DIA Champion and PAREXEL Executive Honored with Global Inspire Award at DIA’s Annual Meeting 2Health News:Longtime DIA Champion and PAREXEL Executive Honored with Global Inspire Award at DIA’s Annual Meeting 3Health News:Co-discoverer of Ebola Virus and AIDS Pioneer to be Honored with Global Inspire Award at DIA’s 2015 51st Annual Meeting 2Health News:Co-discoverer of Ebola Virus and AIDS Pioneer to be Honored with Global Inspire Award at DIA’s 2015 51st Annual Meeting 3Health News:Analysis Reveals Gold Standard Mesothelioma Biomarker Still the Best, According to Surviving Mesothelioma 2Health News:Communities to Recognize Cancer Survivors, Raise Awareness on National Cancer Survivors Day® – Sunday, June 7 2Health News:Communities to Recognize Cancer Survivors, Raise Awareness on National Cancer Survivors Day® – Sunday, June 7 3Health News:Communities to Recognize Cancer Survivors, Raise Awareness on National Cancer Survivors Day® – Sunday, June 7 4Health News:Chief Digital Officer of Travelex joins Bayer, Abellio and Just Eat at The Open Mobile Summit London 2
... Consuming two or more soft drinks per week increased ... compared with individuals who did not consume soft drinks, ... & Prevention , a journal of the American Association ... cancer remains one of the most deadly; only 5 ...
... born prematurely in the US, according to data presented ... findings were reported at the 30th Annual Meeting of ... were published in the latest issue of the ... reported that CP is associated with inflammation of the ...
... research that improves patient safety and surgical outcomes with ... WHO Surgical Safety Checklist was created as a tool ... "With this award AcademyHealth recognizes research that ... care system better," said AcademyHealth President W. David Helms, ...
... TALLAHASSEE, Fla. , Feb. 9 LearnSomething ... drug and mass retailers, today announced that Phil Keough ... company, has joined LearnSomething,s senior management as Chief Business Development ... to continue developing and distributing innovative compliance, operational and sales ...
... The incidence of advanced breast cancer diagnosis among black ... to white women between 1992 and 2004, according to ... Center. In addition, the disparity in the incidence of ... as rates fell among whites but increased slightly among ...
... childhood obesity is directly related to children,s exposure to commercials ... of Public Health study published in the American Journal ... J. Zimmerman and Janice F. Bell, is the first to ... determine whether different kinds of content may exert different effects ...
Cached Medicine News:Health News:Soft drinks may increase risk of pancreatic cancer 2Health News:Incidence of cerebral palsy on rise in US 2Health News:2010 HSR Impact Award recognizes surgical safety research 2Health News:LearnSomething Brings Phil Keough On Board to Spearhead Retail Products and Services 2Health News:LearnSomething Brings Phil Keough On Board to Spearhead Retail Products and Services 3Health News:Racial disparities persist in the diagnosis of advanced breast cancer and colon cancer in the U.S. 2Health News:Racial disparities persist in the diagnosis of advanced breast cancer and colon cancer in the U.S. 3Health News:Racial disparities persist in the diagnosis of advanced breast cancer and colon cancer in the U.S. 4Health News:Childhood obesity: It's not the amount of TV, it's the number of junk food commercials 2
(Date:6/3/2015)... -- Research and Markets  ( http://www.researchandmarkets.com/research/dg23tb/global ) has announced ... 2015-2019" report to their offering. The ... of 5.9% over the period 2014-2019. One ... rise in demand for vials and ampules. The Parenteral ... among all the segments at a CAGR of 8.83 ...
(Date:6/3/2015)... DALLAS , June 3, 2015 ... report "Interventional Cardiology & Peripheral Vascular Devices Market ... Angiography Catheters, EVAR Stent Grafts, IVC Filters, Stents, ... by MarketsandMarkets, the Interventional Cardiology and Peripheral Vascular ... Billion by 2019 with a CAGR of 7.4% ...
(Date:6/3/2015)... 2015  VA North Texas Health Care System ... vBloc, a technology-based, scientifically advanced weight loss therapy.  ... called the Maestro® Rechargeable System that intermittently blocks ... involving food intake and processing between the brain ... customizable to meet the needs of a patient,s ...
Breaking Medicine Technology:Global Pharmaceutical Packaging Market 2015-2019 with Amcor, Bemis Healthcare Packaging, Gerresheimer, MeadWestvaco, Owens-Illinois & West Pharmaceutical Services Dominating 2The Interventional Cardiology and Peripheral Vascular Devices Market Worth $26.72 Billion by 2019 2The Interventional Cardiology and Peripheral Vascular Devices Market Worth $26.72 Billion by 2019 3The Interventional Cardiology and Peripheral Vascular Devices Market Worth $26.72 Billion by 2019 4VA North Texas First VA in the Country to Perform vBloc Implant, a Cutting-Edge Weight Loss Therapy 2VA North Texas First VA in the Country to Perform vBloc Implant, a Cutting-Edge Weight Loss Therapy 3
... NANTONG CITY, China, Oct. 8 /PRNewswire-Asia-FirstCall/ ... (the "Company") is pleased to announce that the Company ... as a pharmaceutical raw material (Certificate #2009S01805) from the ... Gabexate Mesylate is a serine ...
... FRANKLIN LAKES, N.J., Oct. 7 BD (Becton, Dickinson and ... company, today announced that it is pleased to have been ... Rankings" of the 500 largest U.S. corporations based on environmental ... sector and 83rd overall. , Additionally, BD has been ...
Cached Medicine Technology:Chinese Food and Drug Administration Approves Gabexate Mesylate as Pharmaceutical Raw Material 2BD Ranked in the Top 100 Greenest Big Companies by Newsweek; Named Again to Dow Jones Sustainability World and North America Indexes 2
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: